Systems and methods for shifting prescription market share by presenting pricing differentials for therapeutic alternatives
US8630873B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2012 |
| Grant date | Jan 14, 2014 |
| Priority date | — |
| Expiry date | Mar 30, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H20/10
- WIPO fieldIT methods for management
- WIPO sectorElectrical engineering
Abstract
While a pharmacist may know of other medications approved by the FDA for the same medical condition, the pharmacist typically does not know what the therapeutically equivalent dose of those products is when compared to the originally prescribed item. In addition to this lack of equivalent dosage information, the pharmacist also is unable to determine if any of those other FDA approved items will save the consumer any money. Accordingly, embodiments of the invention can provide pharmacists and/or consumers with equivalent dosage information as well as pricing information for the equivalent dosage. Accordingly, based at least in part on this information, consumers may have an incentive to and may decide to purchase to another prescription drug, thereby shifting market share to a preferred prescription drug or pharmaceutical manufacturer or provider.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.